Study finds people with diabetes who fast intermittently may no longer need medication After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical...
Author: Mark Newman
New study leverages Fitbit data to show benefits of active lifestyle on diabetes risk Wearable fitness devices offer new insights into the relationship between physical activity and type 2 diabetes, according to a new analysis of the National Institutes of Health’s All of Us Research Program data published in the Endocrine Society’s Journal of Clinical Endocrinology...
The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. This year, in addition to continuing our virtual advocacy, we had the opportunity to reintroduce several in-person advocacy activities. With help from our members, we successfully advocated for our policy priorities and raised awareness of the value...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
Endocrine Society Weighs in on MPFS; Urges Congress to Avert Scheduled Medicare Cuts
Each year, the Center for Medicare and Medicaid Services (CMS) releases the Medicare Physician Fee Schedule (MPFS) rule, which outlines the agency’s payment and quality program policies for the upcoming year. Medicare policy often sets the bar for the private insurance market as well. Therefore, the payment policies and other revisions in the MPFS are...
Endocrine Society Urges Congress to Complete NIH Appropriations by December 16th Deadline
The Endocrine Society is committed to advocating for increases in the budget of the National Institutes of Health (NIH). Our Hill days, advocacy campaigns, and meetings with appropriators have contributed to increases in the NIH budget over the past seven years. Continued investment in the NIH is critical to further our understanding of endocrine disorders...
As the leaves turn brilliant colors along the Mid-Atlantic, the focus of Endocrine News turns to our annual diabetes research and practice issue each November, to coincide with Diabetes Awareness Month. As usual, thanks to the plethora of research on this topic, we have a packed issue for you. Kelly Horvath delves into the topic...
For many years, the burgeoning cases of diabetes have been at alarming – some would even use the phrase “pandemic” – levels. When the COVID-19 pandemic swept the planet, new solutions to combat diabetes were sorely needed. Endocrine News sits down with Christopher Holliday, PhD, MPH, FACHE, who is heading up the CDC’s Division of...